Long-Term Study Provides Insights into Cognitive Aging: Daily Dose
Your daily dose of the clinical news you may have missed.
How Primary Care Physicians Can Approach the Use of GLP-1 Receptor Agonists for Weight Loss
Michael Crotty, MD, provides practical guidance for on integrating GLP-1 receptor agonists into a comprehensive obesity treatment plan.
New Proposal Seeks to Expand Medicare, Medicaid Coverage for Antiobesity Drugs
The proposal would expand antiobesity drug access for more than 7 million people with Medicare and Medicaid coverage.
CDC Releases Annual STI Report: Daily Dose
Right-Sided Chest Pain, Elevated HR: Seen in the ED
A woman in her early 50s presents with 6 hours of right sided pleuritic chest pain. What do the history and ECG suggest? What's yoru Dx?
For Agitation in Alzheimer Disease, a Novel, Oral NMDA Receptor Antagonist Could be the Next Targeted Treatment
Geriatric psychiatrist and neurocognitive researcher George Grossberg, MD, highlights the mechanism of action for the new dextromethorphan/bupropion combination.
Amgen Reports Promising Phase 2 Data on MariTide for Obesity, Type 2 Diabetes Management
The investigational weight loss drug showed substantial weight loss among people with obesity or overweight with or without T2D without plateaus.
USPSTF Reaffirms Syphilis Screening for Pregnant Individuals Amid Rising Congenital Syphilis Rates
Comments on the draft recommendation can be submitted through December 23, 2024.
Middle-Aged Women Found Down: Seen in the ED
The patient shows no signs of trauma but is a poor historian so no further details are available. Do her vitals or ECG provide any clues to a Dx?
Sex-Specific Dementia Risk in Older Adults with OSA: Daily Dose
GLP-1RAs, SGLT2is Cut Risk of Future MI, Stroke in Survivors: Daily Dose
"Be Vigilant About Risk Factors for COPD, Aggressive with Questions About Symptoms," Expert Advises Primary Care
COPD expert MeiLan K Han, MD, MS, says that in the absence of a definitive single tool to assess for COPD, probing patients for risk factors and symptoms is essential.
Online Misinformation on UTIs, ASB is Common and Dangerous: New Research
At least 1 accurate UTI symptom was found on most of the 331 websites reviewed, but nearly all (80%) included at least 1 inaccurate or misleading one.
Three-Quarters of US Adults Want to Be Asked About Mental Health in Primary Care Visits: New Survey
Approximately 70% of US adults surveyed hope their primary care clinician will ask about their mental health during an appointment, regardless of the presenting issue.
2025 GOLD Report on COPD Addresses Cardiovascular Risk in New Section: MeiLan Han, MD, MS, Highlights Rationale
Cardiovascular comorbidities in adults with COPD are linked to poor outcomes including reduced QoL, increased hospitalizations, and greater risk of mortality, Han explains.
US Trends in Obesity-Related Ischemic Heart Disease Mortality: Daily Dose
Expanding the Obesity Treatment Toolbox: The Promise of Dual-Action Medications
Michael Crotty, MD, an expert in obesity medicine, discusses GLP-1RAs in the context of weight loss, including the novel dual agonist survodutide.
FDA Clears Phase 2 Study of Cannabis for PTSD Treatment in Veterans
After a 3-year negotiation, the FDA has cleared a phase 2 clinical trial assessing the use of smoked cannabis for the treatment of PTSD symptoms in veterans.
Dupilumab, Ensifentrine Added to 2025 GOLD Guidelines for COPD: Expert Parses Recommendations
Professor MeiLan Han, MD, MS, details inclusion of the 2 new medications and how the additions reflect a focus on disease heterogeneity and precision medicine in in COPD.
Sharp Rise in Early-Onset Colorectal Cancer Mortality Among Young US Adults: Daily Dose
